Stay updated with breaking news from Galvani Bioelectronics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
René van der Merwe, MBChB, appointed as Chief Medical Officer Tapan Maniar, Ph.D., joins as Chief Business Officer Company on track to initiate a Phase 2…
The funding for Elon Musk-backed Neuralink was in-part bolstered by FDA’s clearance to start N1 BCI human trials.
Moncef Slaoui speaks with President Donald Trump about Operation Warp Speed in the Rose Garden of the White House on Friday November 13, 2020 in Washington,
Some purchases by bullish investors boosted the valuation in recent months, ahead of Neuralink's May 25 announcement that U.S. regulators had approved a human trial on its brain chip
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CYR4Q36CZJNGVD4DNZEGSMEJCM.jpg)
Elon Musk's brain implant startup Neuralink, which was valued at close to $2 billion in a private fundraising round two years ago, is now worth around $5 billion based on privately executed stock trades described to Reuters by five sources with knowledge of the matter.